Benzinga | Jul 29, 2020 04:37PM EDT

Conmed Q2 Adj. EPS $(0.07), GAAP EPS $(0.96) vs $(0.95) Estimate, Sales $157.80M Beat $126.59M Estimate

Conmed (NYSE:CNMD) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.95) by 92.63 percent. This is a 112.5 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $157.80 million which beat the analyst consensus estimate of $126.59 million by 24.65 percent. This is a 33.77 percent decrease over sales of $238.26 million the same period last year.